Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II Dose.

Name: Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II Dose.
Author: Altzerinakou, Maria-Athina

Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II Dose. — المؤلف: Altzerinakou, Maria-Athina — Journal of the National Cancer Institute 20200615

المؤلف: Altzerinakou, Maria-Athina
النشر: Journal of the National Cancer Institute 20200615
الوصف: 1179-1185 p.
الموضوعات: Antineoplastic Agents؛ Clinical Trials, Phase I as Topic؛ Clinical Trials, Phase II as Topic؛ Drug-Related Side Effects and Adverse Reactions؛ Evidence-Based Medicine؛ Humans؛ Incidence؛ Maximum Tolerated Dose